Hprac psychotherapy review


The College of Nurses of
Ontario
Oral Submission to:
The Standing Committee on Social Policy
BILL 179, REGULATED HEALTH PROFESSIONS
LAW STATUTE AMENDMENT ACT, 2009

September 29, 2009

101 Davenport Road
Toronto ON M5R 3P1
Canada
Telephone: 416 928-0900 Toll-free in Ontario: 1 800 387-5526 Fax: 416 928-6507 E-mail: cno@cnomail.org Web site: www.cno.org Standing Committee on Social Policy
Bill 179 Speaking Notes: College of Nurses of Ontario

Hello, my name is George Fieber. I am a Registered Nurse, Director of Professional Practice at Thunder Bay Regional Health Sciences Centre and President of the College of Nurses of Ontario. With me today is: Anne Coghlan, Executive Director of the College of Nurses. I am pleased to be speaking to you today on behalf of the College, which is the regulatory body for the nursing profession in Ontario. We are pleased to see that many of the changes related to nursing practice that were recommended by the College in 2006 are included in Bill 179. We recommended the changes to improve public access to quality health services, and to improve transparency regarding “who is accountable for what” in Ontario’s health system. The College has provided a written submission to the Standing Committee, which outlines five areas of concern with the Bill. My comments today will elaborate on one issue: nurse practitioner prescribing. There are about 1400 nurse practitioners, also known as “NPs”, registered in Ontario. They work in every corner of this province: large urban cities, rural communities and in remote areas. They provide health services to people of all ages, from all walks of life, with all sorts of health care needs: from those who are healthy and well -- to those who are terminally ill -- and everyone in between. This means people with living diabetes, cancer, heart disease and dementia to name just a few. Standing Committee on Social Policy
Bill 179 Speaking Notes: College of Nurses of Ontario


Nurse practitioners work in every imaginable setting: emergency rooms,
intensive care units, long term care homes, public health units, hospital
wards and community health centres -- this list could easily go on .
I could probably find you an NP who works with just about any patient
population that you could think of.
This diversity in NP practice is the reason why the College of Nurses
does not support a list of drugs for nurse practitioner prescribing and
why we believe the drug list is not in the public interest.
We would like Bill 179 amended to enable broad prescriptive authority
for nurse practitioners.
I don’t think anyone is challenging that NPs are competent to prescribe
drugs: it is part of their education, it is well reflected in their core
competencies and it is a common part of their practice.
The College sets practice standards for safe and ethical NP practice,
including standards for prescribing.
Nurse practitioners currently have access to the controlled act of
prescribing, because they are competent to prescribe drugs.
Let me expand on what I mean when I say NPs are competent.
Prescribing is not a discrete and isolated event. It is an integrated part of
a process of providing health services to patients.
For example:
Before prescribing a drug, the nurse practitioner conducts a health
assessment, a history and a physical exam.
Standing Committee on Social Policy
Bill 179 Speaking Notes: College of Nurses of Ontario

The nurse practitioner formulates a differential diagnosis, which is a
systematic process of elimination through which the NP analyzes
clinical findings and symptoms to narrow down the list of potential
diagnoses.
The NP takes inventory of all medications the patient is taking to reduce
the risk of interactions and potential errors.
After writing the prescription, the nurse practitioner documents it in the
patient’s health record and monitors the patient’s response to treatment.
These are just a few highlights to illustrate to you that prescribing is part
of a continuum.
You can see how critical that entire process is. Patients are at risk if
something goes wrong at any step of the process.
Nurse practitioner education covers that entire continuum: health
assessment, diagnosis and therapeutics.
The College’s registration exams, practice standards and quality
assurance program also cover that continuum.
So, now let me talk about the list and some issues.
First and foremost there is absolutely no connection between a list of
drugs and safe prescribing.
There are currently close to 300 drugs on the NP drug list. Any one of
those can cause harm if prescribed incorrectly.
There is nothing magical about the list that prompts a nurse practitioner
to select the right drug, or choose the right dose to treat the right
condition.
Standing Committee on Social Policy
Bill 179 Speaking Notes: College of Nurses of Ontario

Rather, it is nurse practitioner competencies and the College’s practice
standards in the areas of health assessment, diagnosis and treatment that
promote and guide safe prescribing.
Second: given the diversity in NP practice, and the variety of patient
populations, it would be impossible to predict and list every drug that an
NP may be required to prescribe to meet patient care needs.
An NP only prescribes those drugs that she or he is competent to
prescribe and that are relevant to the patient population with whom she
or he works. This is a standard of practice set by the College.
What this means is that the individual NP is familiar with the specific
drug and understands the particular patient’s condition and symptoms.
The NP understands how and why the specific drug is used to treat this
patient’s condition and whether there are any specific patient factors that
may alter the medication’s desired effect.
This means the NP understands the potential side effects and interactions
the drug may cause, and whether this patient may be at increased risk for
such effects.
It means promoting optimal therapy for the patient, including education
to encourage compliance.
And, it means the NP understands how to monitor the patient taking the
medication to ensure it is having the desired effect – and taking the
necessary steps to follow up if treatment is not working.
So….knowing this I ask -- what added value is there for the patient in
requiring the NP to check a list of drugs?
Standing Committee on Social Policy
Bill 179 Speaking Notes: College of Nurses of Ontario

A list of drugs is not in the public interest because there will always be
an unnecessary delay from when a nurse practitioner may need to
prescribe a particular drug, to when that drug is added to the list.
I can’t tell you how many times this happens with the drug list, and each
and every time it does -- patient care in Ontario is undermined.
The list imposes an artificial barrier between the NP’s competency to
prescribe a drug, and the patient’s right to timely access to treatment.
Finally, we’d like to share our experience with the list over the past 10
years.
The list is rigid – a drug is either on it, or its not.
If the drug is not on the list, then the NP cannot prescribe it.
While the list is rigid, patient care needs are not.
So, I will close with a few real life examples of the negative affect this
list has on patient care.
Twinrix is a combination vaccine that offers dual protection for both
Hepatitis A and Hepatitis B. According to the drug list, NPs can
prescribe both the Hepatitis A and B vaccines, but not the combined
agent because it is not listed.
Does that make sense to you?
Here’s another example. Ciprofloxacin HC ear drops were used to treat
certain ear infections.
The College first asked for this drug to be added to the list in 2002. It
was finally added in 2004.
Standing Committee on Social Policy
Bill 179 Speaking Notes: College of Nurses of Ontario

Then, in 2007, this drug was discontinued – it is no longer available in Canada. Although there are suitable alternatives, NPs cannot prescribe them until they are added to the list. A nurse practitioner in Thunder Bay recently told me that she needed to provide ventolin to a patient who is homeless. However, the list only allows her to “renew” ventolin. This means, it must first be prescribed by a physician, and then the list permits her to order the “repeats”. This patient is homeless. He does not have a physician. Although she is perfectly capable of prescribing ventolin – her best available option that day was to send him to an emergency department to get treatment. My last example will be quick. As I said, the drug list is rigid. A drug is either on it, or not. Seasonal influenza vaccine is on the NP drug list. However, the pandemic H1N1 vaccine is not. These are just a few of the multitude of problems faced by nurse practitioners and their patients every day. This is why the College’s position is that the list of drugs is more harmful to patient care than helpful. This concludes my remarks. We have provided more information in the College’s written submission. I will leave copies of my oral submission. We would be pleased to respond to any questions you may have. Thank you.

Source: http://cno.org/Global/docs/policy/09-25-09vFinalBill179SpeakerNotes.pdf

Ncen28(8).book(ncen_a_150707.fm)

Journal of Clinical and Experimental Neuropsychology , 28:1273–1287, 2006Copyright © Taylor & Francis Group, LLCISSN: 1380-3395DOI: 10.1080/13803390500507246 Neuropsychological Impairment in Obsessive- Compulsive Disorder—Improvement Over the Course of Cognitive Behavioral Treatment . cal Impairment Before and After Therapy ANNE KATRIN KUELZ,1 DIETER RIEMANN,1 ULRIKE HALSBAND

comexbio.org.mx

FILOSOFÍA Y BIOÉTICA DE LA RESPONSABILIDAD SOCIAL EMPRESARIAL Edgar Raúl Navarro Medrano Resumen: El presente trabajo pretende analizar la cuestión de la responsabilidad social de las empresas desde oro punto de vista a la luz de los principios éticos, reflexionando sobre las condiciones que impiden que una empresa sea responsable y dando una perspectiva Palabras Clave

Copyright ©2018 Sedative Dosing Pdf